Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The first robotic-assisted kidney transplant (RAKT) in the Philippines was performed at St Luke’s Medical Center Global City in December 2023. This milestone marks a significant advancement in kidney transplantation within the country. This case series provides the first documentation of the preliminary clinical outcomes of RAKT in the Philippines.
We conducted a retrospective analysis of five (N=5) recipients who underwent living donor robotic-assisted kidney transplantation from December 2023 to March 2025 at St. Luke’s Medical Center, Global City. Data were gathered from the Center for Organ Transplant Registry, with follow-up extending until April 2025. The variables collected included demographics, primary kidney disease, donor relationship, HLA mismatch, dialysis modality and duration, BMI, warm ischemia time, hospitalization length, and post-operative outcomes.
The mean recipient age was 42.2 years (range: 19-63 years), with 60% (n=3) being male. The primary kidney diseases were diabetic kidney disease, polycystic kidney disease, and chronic glomerulonephritis. Two patients underwent preemptive transplantation, while three were on maintenance hemodialysis. Two patients had living-related donors. The BMI of recipients ranged from 17.73 to 59.04, with two patients classified as morbidly obese (BMIs 43.04 and 59.04). Warm ischemia time ranged from 76.8 to 151.8 minutes. The median hospitalization duration was 9 days (range: 6-17 days). All patients demonstrated a significant decline in serum creatinine levels post-transplant, with adequate urine output and stable allograft function throughout the follow-up. No episodes of delayed allograft function, acute rejection, readmission, graft loss, or mortality were observed during the study period.
Table 1. Demographics of Recipients
Patient
Age/Sex
Primary Kidney Diseases
Donor-Recipient Relationship
HLA mismatch
Type of dialysis and duration
BMI
1
19/M
FSGS
Related
1A 1B 1DR
HD/ 1 year
17.73
2
59/F
DKD
Non-related
1A 2B 2 DR
59.04
3
38/M
IgA Nephropathy
1A 2B 1DR
HD/ 9 months
20.24
4
63/M
Polycystic Kidney Disease
2A 2B 1DR
Pre-emptive
43.04
5
32/F
1A 0B 0DR
24.45
Table 2. Operative and Post-Operative Outcomes
Warm Ischemia time (mins)
Duration of Hospitalization (days)
Baseline creatinine
(mg/dl)
Crea upon discharge
Crea after 1 month
Crea after 6 mos
Crea after 1 year
Allograft function
84
6
10.16
1.84
1.37
1.50
1.53
Good
87
17
8.31
1.80
0.80
0.78
151.8
9
12.08
4.01
2.0
1.28
1.5
82
8.40
1.66
1.35
-
76.8
4.18
1.08
Robotic-assisted kidney transplantation represents a promising advancement in kidney transplantation, and the early outcomes in this initial case series are encouraging, showing good allograft function and minimal complications. It may serve as a viable alternative to open surgery, especially for morbidly obese patients who face higher surgical risks. Further studies with larger cohorts are warranted to validate these findings and assess safety and efficacy of robotic-assisted surgery, ultimately improving kidney transplantation outcomes in the Philippines.
